Aaron Borders, Ph.D.

Leading the Migraine MSLs by effectively translating medical strategy into actionable field plans and coaching MSLs to drive deep scientific engagement and build strong relationships with KOLs that align with company objectives.

Product and Project Lead

• Directed alignment of field activities with headquarters-led medical functional strategies. Oversaw support for clinical development during critical enterprise and other clinical trial launches. Participated in workshops to address data gaps and implemented training programs for MSLs. Managed launch execution and coordinated efforts with integrated brand teams and commercial organizations. Championed training and credentialing initiatives for MSLs to optimize field medical insights.
• Coordinated MSL efforts to optimize training for speakers and representatives, ensuring alignment with strategic commercial support objectives, while driving in-field team effectiveness.

Cross-Functional Collaboration and Strategic Leadership

• Achieved effective team build-out by strategically mapping territories and hiring MSLs with a range of skills and backgrounds.
• Support of Medical Functional Planning and tactical field plan implementation
• FD lead for strategic coverage of and reporting on multiple Tier 1 conferences
• Ad Hoc MSL Field Resource review, Veeva and financial compliance reviews
• Mentor through Women Leaders in Action in 2025

Launch and Field Excellence

• Development, communication and execution of launch strategy for 4 launches
• MSL territory and KOL panel development and oversight; development of field goals
• Mentoring MSLs and new Field Directors through new hire training classes (IFTC) and informal mentoring
• Clinical trial support of multiple phase 3 and phase 4 trials
• Collaboration with MedEx to develop year-long MSL and HQ upskill training program
• Lead for quarterly FD Learning Loop with FDs from other TAs for best practice sharing
• 6-month stretch assignment with neurodegeneration pipeline team to gain understanding of early-stage asset strategy development

My leadership blends individual and collaborative empowerment and clarity of purpose, challenging my team to dig deeper to meet our goals of changing practice patterns through provider education, while also achieving professional growth and fulfillment.

Multifaceted and influential Senior MSL with a team-first approach to supporting internal and external stakeholders using excellent communication, integrity, dedication, and leadership. Therapeutic areas supported included movement disorders, physiatry, and migraine.

Product and Project Lead

• Developed MSL launch strategy and field tools for ubrogepant in a cross-functional team
• Orchestrated MSL team training sessions for ubrogepant launch, employing multiple learning modalities, including journal clubs, interactive workshops, and Qstream for enhanced knowledge retention
• Facilitated collaboration with commercial teams to drive successful ubrogepant launch initiatives
• Established a cross-functional collaboration standard with Clinical Development
• Provided timely updates to MSL materials to support field activities
• Organized and planned strategic coverage, networking, and key insight communication of international, national, and regional scientific conferences
• Developed and implemented training program for MSLs to ensure readiness for onabotulinumtoxinA adult lower limb spasticity launch

KOL and Patient Advocacy Engagement

• Consistently met or exceeded yearly field engagement objectives
• Engaged with key opinion leaders across neurology to foster collaborative relationships and enhance knowledge sharing
• Worked with patient advocacy groups to create disease awareness education programs

MSL Mentor

• Mentored five newly hired MSLs, including scientific training, field training and co-rides, and career development
• Proactively coordinated MSL introductions to new KOLs

Key Awards

• Award for Excellence for supporting development and approval of ubrogepant – 2020
• Award for Excellence for training and mentoring new MSLs - 2017
• Number 1 For Patients Delightful Disruption Award for innovative and creative leadership during the 2019 AAN meeting – 2019

Goal- and customer-oriented MSL with the primary objectives to develop and culture relationships with KOLs across multiple specialties, including migraine, movement disorders, physiatry, and urology.

Competitive Differentiation Lead

• Trained MSLs on competitive data, strategies, and messaging
• Engaged with international medical affairs teams to refine competitive messaging and establish effective scientific objection strategies.

MSL Mentor

• Mentored three newly hired MSLs
• Developed a new MSL onboarding training program
• Created and led the MSL Best Field Practices forum series in 2015

• Involved in the design, medicinal chemistry refinement, and preclinical screening of p38 MAPK inhibitors as clinical therapeutic candidates for neuroinflammatory and neurodegenerative diseases, including Alzheimer’s Disease, in a GLP-like cross-functional drug discovery program.
• NIH NRSA F32 Individual Postdoctoral Fellowship Training Grant
• Project Title: “p38 MAPK in AD-related proinflammatory cytokine up-regulation”
• Project Period: July 03, 2008 – May 18, 2010